Science Current Events | Science News | Brightsurf.com
 

Tuberculosis Current Events | Tuberculosis News | 4

Sort By: Page Views | Date

New research may overturn conventional wisdom on drug-resistant tuberculosis
A newly released study suggests that the majority of cases of drug-resistant tuberculosis (TB) among patients undergoing treatment for the disease may be due to new infections, not acquired resistance.   view more (2007-02-21)

What affects the survival of patients with tuberculosis?
As the incidence of tuberculosis (TB) in Canada declines, so too does the experience of physicians with this disease. What impact will this have on patient survival?   view more (2006-09-26)

Iowa State University researcher uncovers potential key to curing tuberculosis
Researchers at Iowa State University have identified an enzyme that helps make tuberculosis resistant to a human's natural defense system. Researchers have also found a method to possibly neutralize that enzyme, which may someday lead to a cure for tuberculosis.    view more (2009-10-02)

A possible ancient origin for tuberculoses in Casablanca
Each year tuberculosis kills about three million people in the world. In particular it is responsible for the death of more than one-third of HIV- infected people, who prove particularly susceptible owing to a decline in immune defences. The agent responsible is a bacterium of the species Mycobacterium tuberculosis, also termed Koch's bacillus,... view more... (2004-11-23)

Unusual carbohydrate structure in the cell walls of tuberculosis bacteria-a new point of attack for drugs?
Even though we have lost much of our fear of tuberculosis in the industrialized countries, according to the WHO about 2 mio. people worldwide die each year of this infectious disease. Researchers at the University of Leeds have now discovered a carbohydrate with an unusual structure in the cell walls of Mycobacterium tuberculosis, the bacterium... view more... (2004-07-27)

UCLA develops safer, more effective TB vaccine for HIV-positive people
UCLA scientists engineered a new tuberculosis (TB) vaccine specifically designed for HIV-positive people that was shown to be safer and more potent than the current TB vaccine in preclinical trials.   view more (2008-10-24)

Patients with tuberculosis should be more involved in decisions about their treatment
Tuberculosis (TB) is a major killer, causing up to two million deaths worldwide every year. Treatment takes many months and many patients fail to complete the course of drugs prescribed.   view more (2007-07-24)

Patients with TB should be more involved in decisions about their treatment
Tuberculosis (TB) is a major killer, causing up to two million deaths worldwide every year. Treatment takes many months and many patients fail to complete the course of drugs prescribed.   view more (2007-07-24)

Tuberculosis Diagnostics Within Several Minutes
A single glance at the patient's blood plasma will now be sufficient to ascertain whether he/she is ill with tuberculosis, and should the diagnosis be unfavourable - to determine the stage of the disease. Certainly, the plasma will be viewed through the device developed by the specialists of the Sechenov Moscow Medical Academy and their colleagues... view more... (2004-12-10)

Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence
New findings show a link between micronutrient supplementation and reduced risk of recurrence during tuberculosis chemotherapy, according to a study published in the June 1 issue of The Journal of Infectious Diseases, now available online.   view more (2008-04-28)

Tuberculosis risks for health workers in developing countries
Latent infection with tuberculosis is common and some infected people develop the active form of the disease. Health-care workers (HCWs) can become infected, develop active disease, and c an pass their infection on to patients and others.   view more (2006-12-26)

Parasites that live inside cells use loophole to thwart immune system
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide.   view more (2008-11-04)

Drug industry, nonprofits join forces to fight world's neglected diseases
Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year.   view more (2009-11-12)

Pitt-led Researchers Find Source of Drug-Tolerant Tuberculosis Possibly Behind TB Relapses, Intensity of Treatment
University of Pittsburgh-led researchers discovered that the primary bacteria behind tuberculosis can grow on surfaces and that drug-tolerant strains flourish in these bacterial communities, the research team recently reported in "Molecular Microbiology."   view more (2008-06-12)

Pilot study reinforces use of portable anteroom HEPA filtration
Amidst an increase in new tuberculosis cases, researchers have begun investigating the effectiveness of new operating room filtration systems designed to protect staff and patients.   view more (2008-05-07)

Alarming new data shows TB-HIV co-infection a bigger threat
The World Health Organization released staggering new data about the threat of tuberculosis and the toll it takes on people with HIV/AIDS today, in recognition of World TB Day.   view more (2009-03-25)

US investment in tuberculosis control abroad pays off at home
A new study to be published in tomorrow's New England Journal of Medicine shows that United States investment in tuberculosis (TB) treatment abroad saves lives and money at home.   view more (2005-09-08)

Abandoned bones suggest TB wiped out leprosy in battle of killer diseases
The spread of tuberculosis may have killed off leprosy in Europe in the Middle Ages, according to research published in the latest issue of the Royal Society Proceedings B.   view more (2005-02-07)

Patient adherence for successful tuberculosis treatment
Nearly 2 million people die from tuberculosis each year, mainly in the poorest countries. The pathogen, Koch's bacillus, can pass easily by aerial infection from one individual to another.   view more (2007-03-28)

UAB Researchers Find TB-Prevention Therapy Is Cost-Effective Option
University of Alabama at Birmingham (UAB) researchers have found that the cost of preventive antibiotic tuberculosis (TB) therapy for patients infected by human immunodeficiency virus (HIV) is generally less expensive than the reported cost of treating newly confirmed TB cases.   view more (2009-09-10)
Sort By: Page Views | Date
© 2009 BrightSurf.com